Invention Grant
- Patent Title: Bicyclic compounds as dual ATX/CA inhibitors
-
Application No.: US15933701Application Date: 2018-03-23
-
Publication No.: US10647719B2Publication Date: 2020-05-12
- Inventor: Patrick Di Giorgio , Jerome Hert , Daniel Hunziker , Patrizio Mattei , Markus Rudolph , Petra Schmitz , Christoph Ullmer
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Katherine J. Mackenzie
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@c698c59
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/04 ; A61P27/02 ; A61K31/407 ; A61K31/437 ; A61K31/5517
Abstract:
The invention provides novel compounds having the general formula (I) wherein R1, R2, Y, W, m, n, p and q are as defined herein, compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20180215765A1 NEW BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS Public/Granted day:2018-08-02
Information query
